The results showed that the mRNA expression of SPHK1 and HAS2 was significantly higher in pancreatic cancer group (177 cases) than those of the healthy control (173 cases) (P < 0.05 and P < 0.05), respectively (Figure 1(a)). This evidence concerns the gene HAS2 and pancreatic neoplasm.